Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Schizophrenia Agitation”

51 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 51 results

Large-scale testing (Phase 3)Study completedNCT00485901
What this trial is testing

Comparison of Intramuscular Olanzapine and Intramuscular Haloperidol in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Eli Lilly and Company 50
Post-approval studies (Phase 4)Study completedNCT00954122
What this trial is testing

Efficacy and Safety of SEROQUEL Extended Release (XR) in Acute Schizophrenia

Who this might be right for
Schizophrenia
AstraZeneca 35
Not applicableStudy completedNCT00174200
What this trial is testing

Study To Assess Differential Sensitivity Of 2 Spatial Working Memory Tests In Schizophrenics Treated With Risperidone

Who this might be right for
SchizophreniaPsychotic Disorders
Pfizer 20
Large-scale testing (Phase 3)Study completedNCT00136994
What this trial is testing

IM and Oral in Acute Exacerbation of Schizophrenia (BIZET Study)

Who this might be right for
Schizophrenia
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 160
Post-approval studies (Phase 4)WithdrawnNCT05974527
What this trial is testing

Pilot Study 1: Efficacy and Safety of Sublingual Dexmedetomidine (BXCL501) for the Treatment of Agitation in the Emergency Department

Who this might be right for
AgitationSchizophreniaSchizoaffective Disorder+2 more
Brigham and Women's Hospital
Large-scale testing (Phase 3)UnknownNCT05803642
What this trial is testing

Olanzapine in Patients With Acute Agitation

Who this might be right for
Acute Agitation
Qilu Pharmaceutical Co., Ltd. 318
Testing effectiveness (Phase 2)Study completedNCT00485810
What this trial is testing

Examining Rapid Acting Intra-Muscular Olanzapine in Japanese Patients With Schizophrenia

Who this might be right for
Schizophrenia
Eli Lilly and Company 31
Post-approval studies (Phase 4)UnknownNCT02935998
What this trial is testing

The Efficacy And Safety Of Intramuscular Ziprasidone For Three Days In Patients With Psychotic Agitation

Who this might be right for
Schizophrenia
Yang Fude 1,000
Post-approval studies (Phase 4)Study completedNCT02525991
What this trial is testing

Phase IV to Evaluate the Safety of Self-administered ADASUVE® in Agitated Patients Outside the Hospital Setting

Who this might be right for
Agitation
Ferrer Internacional S.A. 323
Large-scale testing (Phase 3)Study completedNCT00797277
What this trial is testing

Intramuscular (IM) Olanzapine Versus IM Haloperidol Plus Lorazepam for Acute Agitation in Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective DisorderAgitation
National Taiwan University Hospital 67
Large-scale testing (Phase 3)Study completedNCT04268303
What this trial is testing

Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia

Who this might be right for
AgitationSchizophreniaSchizo Affective Disorder+2 more
BioXcel Therapeutics Inc 380
Large-scale testing (Phase 3)Study completedNCT00866645
What this trial is testing

Evaluate The Efficacy And Safety Of Intramuscular Levosulpiride In Patients With Agitation Of Schizophrenia

Who this might be right for
Agitation
Shanghai Mental Health Center 240
Not applicableStudy completedNCT00065286
What this trial is testing

Akathisia (Restless Legs Syndrome) in People With Schizophrenia and Mental Retardation

Who this might be right for
Akathisia
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Post-approval studies (Phase 4)UnknownNCT06093451
What this trial is testing

Evaluating Sublingual Dexmedetomidine For Moderate To Severe Agitation In Inpatients With Schizophrenia Or Bipolar Disorder

Who this might be right for
Schizophrenia AgitationSchizo Affective DisorderBipolar Disorder+1 more
Temple University 32
Post-approval studies (Phase 4)Study completedNCT00417482
What this trial is testing

Antipsychotic Discontinuation in Alzheimer's Disease

Who this might be right for
Alzheimer DiseasePsychotic DisordersAgitation+1 more
New York State Psychiatric Institute 180
Large-scale testing (Phase 3)Study completedNCT00455234
What this trial is testing

Rapid Tranquillization Trial: TREC-India II

Who this might be right for
Psychotic DisordersAggression
Christian Medical College, Vellore, India 300
Not applicableTemporarily pausedNCT03513549
What this trial is testing

Observational Study Evaluating the Safety of ADASUVE® in Agitation Associated With Schizophrenia or Bipolar I Disorder

Who this might be right for
Agitation,Psychomotor
Alexza Pharmaceuticals, Inc. 10,000
Not applicableEnded earlyNCT00515489
What this trial is testing

Study on the Safety and Effectiveness of Risperidone Treatment of Acute Psychotic Patients

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorders
Janssen-Cilag, S.A. 1,882
Not applicableStudy completedNCT00015548
What this trial is testing

CATIE-Alzheimer's Disease Trial

Who this might be right for
Alzheimer's Disease
National Institute of Mental Health (NIMH) 450
Large-scale testing (Phase 3)Study completedNCT00628589
What this trial is testing

Staccato Loxapine in Agitated Patients With Schizophrenia

Who this might be right for
Patients With Schizophrenia and Acute Agitation
Alexza Pharmaceuticals, Inc. 344
Load More Results